WHITEHOUSE STATION, N.J.--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved GRASTEK® (Timothy Grass ...

The US Food and Drug Administration (FDA) has approved Timothy Grass Pollen Allergen Extract Tablet for Sublingual Use Grastek, Merck & Co, Inc) for the treatment of Timothy grass pollen-induced ...

The Allergenic Products Committee of the US Food and Drug Administration (FDA) voted unanimously to recommend Timothy Grass Pollen Allergen Extract Tablet for Sublingual Use (MK-7243) (Grastek, Merck ...

Merck picked up an expected FDA approval for the first of three immunotherapies in its allergy pipeline, gearing up to launch a grass pollen-fighting treatment with hopes of cracking a market ...

Timothy (Phleum pratense) is a perennial cool season grass that is relatively late flowering and best adapted to cool, humid climates. It normally matures two to three weeks later than tall fescue, ...

AMHERST, Mass. – Results of a new study by scientists at the University of Massachusetts Amherst strongly suggest that there will be notable increases in grass pollen production and allergen exposure ...

The US Food and Drug Administration (FDA) approved Paris-based Stallergenes' Oralair for grass pollen–induced allergic rhinitis on April 1, making it the first oral immunotherapy to reach the US ...

ABSTRACT: Interactions between soil properties and climate affect forage grass productivity. Dynamic models, simulating crop performance as a function of environmental conditions, are valid for a ...